PRESS RELEASE

Oct 29, 2026
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
Read More
Oct 08, 2026
BioStem Technologies' CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
Read More
Oct 01, 2026
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
Read More
Sep 30, 2026
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Read More
Sep 21, 2026
Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
Read More
Sep 18, 2026
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
Read More
Sep 04, 2026
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
Read More
Sep 03, 2026
BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Read More
Aug 14, 2026
BioStem Technologies to Present at the Sidoti MicroCap Conference
Read More
Aug 12, 2026
BioStem Technologies Reports Second Quarter 2026 Financial Results
Read More
Load more news